Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 402

The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.

Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain

Open access
Milano, Michael T., Grimm, Jimm, Niemierko, Andrzej, Soltys, Scott G., Moiseenko, Vitali, Redmond, Kristin J., Yorke, Ellen, Sahgal, Arjun, Xue, Jinyu, Mahadevan, Anand, Muacevic, Alexander, Marks, Lawrence B., Kleinberg, Lawrence R.·2021·International Journal of Radiation Oncology*Biology*Physics

Abstract

Purpose/Objective(s) As part of the American Association of Physicists in Medicine (AAPM) Working Group on Stereotactic Body Radiotherapy, investigating normal tissue complication probability (NTCP) after hypofractionated radiotherapy, data from published reports (PubMed indexed 1995–2018) were pooled to identify dosimetric and clinical predictors of radiation-induced brain toxicity after single-fraction stereotactic radiosurgery (SRS) or fractionated stereotactic radiosurgery (fSRS). Materials/Methods Eligible studies provided normal tissue complication probabilities (NTCPs) for the endpoints of radionecrosis, edema, or symptoms after cranial SRS/fSRS, and quantitative dose-volume metrics. Studies of patients with only glioma, meningioma, vestibular schwannoma, or brainstem targets were excluded. The data summary and analyses focused on arteriovenous malformations (AVM) and brain metastases. Results Data from 51 reports are summarized. There was wide variability in reported rates of radionecrosis. Available data for SRS/fSRS for brain metastases were more amenable to NTCP modeling than AVM data. In the setting of brain metastases, SRS/fSRS-associated RN can be difficult to differentiate from tumor progression. For single-fraction SRS to brain metastases, volumes receiving 12 Gy (V12), including the target volumes, of 5 cc, 10 cc, or >15 cc were associated with risks of symptomatic radionecrosis of approximately 10%, 15%, and 20%, respectively. SRS for AVM was associated with modestly lower rates of symptomatic radionecrosis for equivalent V12. For 3-fraction fSRS for brain metastases, normal brain tissue V18 <30 cc and V23 <7 cc were associated with <10% risk of radionecrosis. Conclusions The risk of radionecrosis after SRS and fSRS can be modeled as a function of dose and volume treated. The use of fSRS appears to reduce risks of radionecrosis for larger treatment volumes relative to SRS. More standardized dosimetric and toxicity reporting is needed to facilitate future pooled analyses that can refine predictive models of brain toxicity risks.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijrobp.2020.08.013

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 71 references

Cited by

See all 402

Metadata

Authors
Milano, M. T., Grimm, J., Niemierko, A., Soltys, S. G., Moiseenko, V., Redmond, K. J., Yorke, E., Sahgal, A., Xue, J., Mahadevan, A., Muacevic, A., Marks, L. B., & Kleinberg, L. R.
Venue
International Journal of Radiation Oncology*Biology*Physics
Publisher
Elsevier BV
Published
2021-05
Volume
110
Issue
1
Pages
68-86
ISSN
0360-3016 (ISSN-L)
OpenAlex
W3085200879
Cited by
402
References
71
FWCI
21.43
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain. https://app.cochat.ai/papers/10.1016/j.ijrobp.2020.08.013
The paper
Milano, M. T., Grimm, J., Niemierko, A., Soltys, S. G., Moiseenko, V., Redmond, K. J., Yorke, E., Sahgal, A., Xue, J., Mahadevan, A., Muacevic, A., Marks, L. B., & Kleinberg, L. R. (2021). Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2020.08.013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.